M
MBX
MBX Biosciences Inc
62.91
-0.08-0.13%After Hours: 62.91 0.00 0.00%19:30 09/09 EDT
OPEN/PREV CLOSE63.29/62.99
TODAY RANGE61.29-64.04
VOL315.69K
MARKET CAP3.03B
52 WEEK RANGE9.63-72.64
AVG VOL (3M)730.23K
% TURNOVER0.66%
TURNOVER--
P/E (TTM)-26.1537
% RANGE4.37%
EPS(TTM)-2.4054
P/E(FORWARD)-19.9959
P/B7.37
BVPS8.54
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.33B
SHARES OUTSTANDING48.16M
NEXT EARNINGS11/04-11/09
FREE FLOAT37.08M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·6d ago
MBX Biosciences (MBX) Is Down 7.5% After Starting Phase 3 oPTimize Trial – Has The Bull Case Changed?
Seeking Alpha·08/28 22:00
Septerna: GPCR Programs May Be Experimental, But I'm Holding For The Long Term
Simply Wall St·08/28 08:26
MBX Biosciences (MBX), Why Is It Getting So Much Attention Now?
TipRanks·08/27 12:58
MBX Biosciences Begins Pivotal Phase 3 Canvuparatide Trial
TipRanks·08/27 12:10
MBX Biosciences doses first patient in oPTimize clinical trial
Dow Jones·08/21 19:12
MBX Biosciences Price Target Announced at $88.00/Share by JP Morgan
Benzinga·08/21 19:01
JP Morgan Reinstates Overweight on MBX Biosciences, Announces $88 Price Target
TipRanks·08/21 10:31
MBX Biosciences reinstated with an Overweight at JPMorgan
Barron‘s·08/14 23:06
13D Filings
Dow Jones·08/10 18:22
MBX Biosciences Is Maintained at Buy by Truist Securities
Dow Jones·08/10 18:22
MBX Biosciences Price Target Raised to $88.00/Share From $70.00 by Truist Securities
Benzinga·08/10 18:11
Truist Securities Maintains Buy on MBX Biosciences, Raises Price Target to $88
TipRanks·08/10 14:15
MBX Biosciences price target raised to $88 from $70 at Truist
Same Industry
Name/Symbol
Change%
Price